Executive Medical Director, Cell Therapy Development

Regeneron Pharmaceuticals, Inc.; Village of Tarrytown (NY); On-site; USD 398,000 - 538,000; Full time

Job summary

Regeneron is seeking an Executive Medical Director to provide clinical scientific leadership for our Cell Therapy program, overseeing development strategy and execution of trials in hematology, and guiding a team of MDs and clinical scientists.

Location options include Tarrytown, NY or Warren, NJ; travel up to 10% to conferences. This role collaborates with external authorities and internal partners to shape data-driven development plans and to accelerate programs while delivering patient impact.

Qualifications

• MD or equivalent degree required.
• 6-8 years of industry experience in related therapeutic area clinical development.
• Experience with IND and BLA/NDA submissions.
• Leadership experience with senior clinical development staff and external collaborators such as regulators.

Responsibilities

• Serve as medical expert and leader in interactions with external collaborators (regulatory authorities, key opinion leaders, advisory boards) and internal teams.
• Develop and defend data-driven plans and decisions addressing regulatory and scientific challenges.
• Design innovative clinical strategies to shorten development cycles and manage Phase 2/3 programs.
• Lead multi-disciplinary teams toward sound decision-making in a fast-paced environment.
• Lead and develop a team of MDs and clinical scientists to meet business needs.

Skills

Clinical leadership

Team leadership

Data-driven decision making

Education

MD or equivalent

Hematology/Oncology fellowship

Job description

Regeneron is seeking an Executive Medical Director to provide clinical scientific leadership for our Cell Therapy program, overseeing development strategy and execution of trials in hematology, and guiding a team of MDs and clinical scientists.

Location options include Tarrytown, NY or Warren, NJ; travel up to 10% to conferences. This role collaborates with external authorities and internal partners to shape data-driven development plans and to accelerate programs while delivering patient impact.